Arnatar Therapeutics
- Business Model
- B2B
- Website
- arnatar.com
- Total Funding
- $52.0M
- Last Round
- $52.0M Series AApr 2024
- Rounds
- 1
About
Clinical-stage biotech company developing RNA medicine using its DARGER platform for rare diseases.
Summary
Arnatar Therapeutics is a Biotech company. It has raised $52.0M in total across 1 round, most recently a $52.0M Series A round in Apr 2024. Investors include Eight Roads Ventures, 3E Bioventures Capital and F-Prime Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...